← All stocks

BridgeBio Oncology Therapeutics, Inc.

BBOT No buying or selling

CIK 0001869105 #2802 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BridgeBio Pharma LLC entity

10% owner

—

14,589,846

18.20%

$145.90M

+5.7%

Chen Bihua

Director

—

6,083,221

7.59%

$60.83M

—

Ben Yong

Chief Med & Dev Officer

—

44,576

0.0556%

$445.76K

—

Beltran Pedro

President and CEO

—

44,576

0.0556%

$445.76K

—

McKenna Mark C.

Former Director

—

30,000

0.0374%

$300.00K

—

Schmid John P.

Former Director

—

30,000

0.0374%

$300.00K

—

Holman Albert A III

Former Director

—

30,000

0.0374%

$300.00K

—

Mehra Uneek

Former Officer

—

22,806

0.0284%

$228.06K

—

Elmelech Idan

COO & Principal Financial Ofcr

—

14,495

0.0181%

$144.95K

−2.3%

Cobo Marc

Principal Accounting Officer

—

14,141

0.0176%

$141.41K

+160.4%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 9,241

History held since 13 Feb 2024